article thumbnail

The Rise of Cannabis Pre-rolls: Data Analysis Reveals Surging Popularity

Veriheal

In the fast-paced, data-driven world of the cannabis industry, partnerships are crucial to success. Turns out, his statements are backed up by thorough data analysis and insightful findings. Conversely, “wellness” counterparts such as capsules, tinctures, and topicals are experiencing a decline in market share.

Data 98
article thumbnail

Leafreport….”CBD Pricing Report: The Price Difference between the Cheapest and Most Expensive Topicals Increases to 11142%”

Cannabis Law Report

Price Difference between the Cheapest and Most Expensive Topicals Increases to 11142%. billion in 2020, a landmark feat considering hemp-derived cannabinoids only became federally legal in 2018. We carry out an in-depth pricing analysis, collecting data to compare the prices of more than 3000 CBD products from more than 100 brands.

Topical 97
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna’s Evidence-Based Topical Products through Heritage’s Medical Opticann Brands

Cannabis Law Report

Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98
article thumbnail

Congress Wants to Hear from You on CBD by August 18th

Canna Law Blog

Today’s public service announcement is that Congress wants to hear from you on a regulatory fix for cannabidiol (CBD) and other hemp-derived cannabinoid products. The request came down via the Energy and Commerce Committee on July 27, when it published a Request for Information ( RFI ) to “interested parties” on the topic.

CBD 72
article thumbnail

Hemp Roundtable: Updates in ID, KY, MI, and VA

Cannabis Law Report

As we reported last month , Virginia convened a task force to make recommendations for the manufacture and sale of hemp extracts, pursuant to recently-passed HB 30. The rule does not apply to topical products, but it would treat as marijuana most full and broad spectrum hemp products.

Hemp 52
article thumbnail

US Hemp Roundtable Analyses FDA’s CBD Report To Congress

Cannabis Law Report

More than a week after a Congressional deadline, FDA finally released its long-awaited report to Congress on the potential regulatory pathways for the sale of hemp-derived CBD products. FDA is re-opening the docket to obtain information on “full spectrum” and “broad spectrum” hemp extracts, and how they compare to CBD isolate products.

Hemp 64
article thumbnail

US Hemp Roundtable Analysis Of FDA CBD Report To Congress

Cannabis Law Report

More than a week after a Congressional deadline, FDA finally released its long-awaited report to Congress on the potential regulatory pathways for the sale of hemp-derived CBD products. FDA is re-opening the docket to obtain information on “full spectrum” and “broad spectrum” hemp extracts, and how they compare to CBD isolate products.

Hemp 71